Ophthalmology, Glaucoma Specialist · Seattle, WA
NPI
1629006135
Since 2006
Specialty
Ophthalmology, Glaucoma Specialist
Code 207WX0009X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1101 Madison St, Ste 600
Seattle, WA, 98104
Phone (206) 215-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$293K
4,678 services
Medicare patients, 2024
595
Average age 77
Drug cost, 2024
$990K
5,650 prescriptions
Company payments, 2025
$688
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Annisa L Jamil was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 1,003 times for 23 patients. In total Annisa L Jamil billed 4,678 services in 46 codes, and Medicare paid $293K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,003 | 23 | $0.09 | $90.5 |
| 99214 Office E&M - Established | Office | 786 | 405 | $98.58 | $77K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 589 | 145 | $53.46 | $31K |
| 92133 Computerized Ophthalmic Imaging | Office | 386 | 362 | $28.64 | $11K |
| 92083 Vision, Hearing, and Speech Services | Office | 331 | 310 | $52.29 | $17K |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 278 | 122 | $41.11 | $11K |
| 92014 Ophthalmological E&M | Office | 274 | 258 | $93.77 | $26K |
| 92250 Angiography | Office | 187 | 186 | $29.18 | $5,456 |
| 99213 Office E&M - Established | Office | 151 | 117 | $69.59 | $11K |
| 92020 Ophthalmological E&M | Office | 140 | 131 | $21.93 | $3,070 |
| 92136 Ultrasound - Nonspecific | Office | 75 | 55 | $37.32 | $2,799 |
| J9190 Injection, fluorouracil, 500 mg | Office | 60 | 23 | $2.28 | $137 |
| 76514 Ultrasound - Nonspecific | Office | 59 | 59 | $8.81 | $520 |
| 68200 Eye | Office | 57 | 23 | $36.74 | $2,094 |
| 99204 Office E&M - New | Office | 49 | 49 | $142.66 | $6,990 |
By year: 2022 $279K for 3,087 services; 2023 $287K for 3,618 services; 2024 $293K for 4,678 services.
Medicare prescription drug claims, 2024
In 2024, the drug Annisa L Jamil prescribed most often to Medicare patients was Latanoprost, with 784 prescriptions and refills. In total Annisa L Jamil wrote 5,650 Medicare prescriptions that cost $990K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 784 | 1,671 | 222 | $10K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 721 | 1,498 | 196 | $12K |
| Brimonidine Tartrate Generic | 555 | 1,166 | 162 | $11K |
| Vyzulta Latanoprostene Bunod | 538 | 1,012 | 176 | $276K |
| Timolol Maleate Generic | 513 | 1,088 | 157 | $5,566 |
| Rhopressa Netarsudil Mesylate | 338 | 550 | 84 | $180K |
| Moxifloxacin Moxifloxacin Hcl | 329 | 330 | 167 | $6,678 |
| Prednisolone Acetate Generic | 228 | 309 | 107 | $9,072 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 188 | 370 | 58 | $28K |
| Difluprednate Generic | 183 | 189 | 65 | $18K |
| Dorzolamide Hcl Generic | 167 | 384 | 57 | $3,839 |
| Lumigan Bimatoprost | 150 | 345 | 46 | $92K |
| Simbrinza Brinzolamide/Brimonidine Tart | 135 | 249 | 38 | $42K |
| Combigan Brimonidine Tartrate/Timolol | 103 | 237 | 35 | $49K |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 93 | 172 | 32 | $17K |
Brand drugs: 2,165 claims; generic drugs: 3,485 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Annisa L Jamil $688 ($688 in general payments such as food, travel and fees) from 10 companies. The largest payer was Alcon Vision LLC with $159.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 3 | $159 |
| Abbvie Inc. ABBV | 7 | $148 |
| Bausch & Lomb Americas Inc. BLCO | 5 | $107 |
| Glaukos Corporation GKOS | 2 | $69.33 |
| Dompe US, Inc. | 2 | $65.42 |
| Tarsus Pharmaceuticals, Inc. TARS | 2 | $51.79 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $27.39 |
| Biotissue Holdings Inc. | 1 | $23.95 |
| Thea Pharma Inc. | 1 | $18.31 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $17.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.